CSF Aβ 1–42 – an excellent but complicated Alzheimer's biomarker – a route to standardisation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CSF Aβ 1–42 – an excellent but complicated Alzheimer's biomarker – a route to standardisation

Published:2017-04 Issue: Volume:467 Page:27-33
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Kuhlmann Julia,Andreasson Ulf,Pannee Josef,Bjerke Maria,Portelius Erik,Leinenbach Andreas,Bittner Tobias,Korecka Magdalena,Jenkins Rand G.,Vanderstichele Hugo,Stoops Erik,Lewczuk Piotr,Shaw Leslie M.,Zegers Ingrid,Schimmel Heinz,Zetterberg Henrik,Blennow Kaj

Funder

Alzheimer's Association

Swedish Brain Foundation

Swedish Research Council

Knut and Alice Wallenberg Foundation

Royal Swedish Academy of Sciences

Torsten Söderberg Foundation

JPNDBIOMARKAPD

NIA/NIH ADNI

German Bundesministerium für Bildung und Forschung

Innovative Medicines Initiative

European Union's Seventh Framework Programme

EFPIA

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference27 articles.

1. Cerebrospinal fluid and plasma biomarkers in Alzheimer's disease;Blennow;Nat. Rev. Neurol.,2010

2. CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study;Strozyk;Neurology,2003

3. Biomarkers for Alzheimer's disease: academic industry and regulatory perspectives;Hampel;Nat. Rev. Drug Discov.,2010

4. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study;Hansson;Lancet Neurol.,2006

5. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects;Shaw;Ann. Neurol.,2009

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring advancements in early detection of Alzheimer's disease with molecular assays and animal models;Ageing Research Reviews;2024-09

2. The CentiMarker Project: Standardizing Quantitative Alzheimer’s disease Fluid Biomarkers for Biologic Interpretation;2024-07-27

3. Quantitative systems pharmacology‐based exploration of relevant anti‐amyloid therapy challenges in clinical practice;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2024-04

4. Progranulin and neuropathological features of Alzheimer’s disease: longitudinal study;Aging Clinical and Experimental Research;2024-03-05

5. Microfluidics as diagnostic tools;Clinica Chimica Acta;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3